See more : SpareBank 1 Helgeland (HELG.OL) Income Statement Analysis – Financial Results
Complete financial analysis of Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Yixintang Pharmaceutical Group Co., Ltd., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- China Lesso Group Holdings Limited (2128.HK) Income Statement Analysis – Financial Results
- Fairfax Financial Holdings Limited (FRFXF) Income Statement Analysis – Financial Results
- The Home Depot, Inc. (HD) Income Statement Analysis – Financial Results
- Cemepe Investimentos S.A. (MAPT4.SA) Income Statement Analysis – Financial Results
- Cerberus Telecom Acquisition Corp. (CTAC-UN) Income Statement Analysis – Financial Results
Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ)
About Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Group Co., Ltd., together with its subsidiary, operates a chain of drugstores in China. It also produces and sells medicinal materials, Chinese herbal medicines, and food and health products, as well as engages in the drug distribution activities. As of January 31, 2020, the company operated 7,205 stores in Yunnan, Guizhou, Guangxi, Sichuan, Shanxi, Chongqing, Tianjin, Shanghai, Qiong, and other provinces and municipalities. It also sells products online. The company was formerly known as Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. and changed its name to Yixintang Pharmaceutical Group Co., Ltd. in June 2019. Yixintang Pharmaceutical Group Co., Ltd. was founded in 2000 and is headquartered in Kunming, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17.30B | 17.43B | 14.59B | 12.66B | 10.48B | 9.18B | 7.75B | 6.25B | 5.32B | 4.43B | 3.55B | 2.84B | 2.22B | 1.85B | 1.46B |
| Cost of Revenue | 11.75B | 11.32B | 9.20B | 8.12B | 6.42B | 5.46B | 4.53B | 3.67B | 3.09B | 2.64B | 2.14B | 1.76B | 1.36B | 1.16B | 924.98M |
| Gross Profit | 5.55B | 6.11B | 5.39B | 4.53B | 4.05B | 3.72B | 3.22B | 2.58B | 2.23B | 1.79B | 1.40B | 1.08B | 862.60M | 690.25M | 531.00M |
| Gross Profit Ratio | 32.08% | 35.05% | 36.96% | 35.82% | 38.70% | 40.53% | 41.52% | 41.28% | 41.92% | 40.44% | 39.59% | 38.15% | 38.88% | 37.31% | 36.47% |
| Research & Development | 10.20M | 8.74M | 5.39M | 839.49K | 238.51K | 146.39K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 79.33M | 67.07M | 64.61M | 68.66M | 72.44M | 55.41M | 49.65M | 56.11M | 60.22M | 47.74M | 29.74M | 42.93M | 35.03M | 104.23M | 77.44M |
| Selling & Marketing | 640.15M | 4.07B | 3.70B | 3.05B | 2.83B | 2.45B | 2.16B | 1.75B | 1.48B | 1.12B | 919.22M | 693.71M | 551.90M | 444.65M | 327.98M |
| SG&A | 4.68B | 4.14B | 3.77B | 3.12B | 2.91B | 2.51B | 2.21B | 1.81B | 1.54B | 1.17B | 948.96M | 736.64M | 586.93M | 548.89M | 405.42M |
| Other Expenses | 90.11M | 349.13M | 320.56M | 437.65M | 343.33M | 414.34M | 367.83M | 18.45M | 12.84M | 2.37M | 6.42M | 6.33M | 2.03M | 2.38M | -4.54M |
| Operating Expenses | 4.78B | 4.50B | 4.09B | 3.56B | 3.25B | 2.92B | 2.57B | 2.11B | 1.79B | 1.39B | 1.12B | 867.41M | 694.52M | 559.78M | 414.47M |
| Cost & Expenses | 16.59B | 15.82B | 13.29B | 11.68B | 9.67B | 8.38B | 7.11B | 5.78B | 4.88B | 4.02B | 3.26B | 2.63B | 2.05B | 1.72B | 1.34B |
| Interest Income | 77.57M | 53.40M | 39.25M | 24.17M | 18.97M | 12.38M | 10.73M | 12.24M | 13.62M | 8.65M | 6.34M | 4.88M | 4.05M | -0.01 | -0.19 |
| Interest Expense | 135.34M | 147.12M | 136.22M | 24.54M | 33.71M | 47.60M | 57.61M | 37.45M | 20.41M | 8.10M | 12.92M | 12.41M | 10.02M | 4.83M | 5.96M |
| Depreciation & Amortization | 1.33B | 1.15B | 1.21B | 239.43M | 246.91M | 180.69M | 119.42M | 97.86M | 51.51M | 37.36M | 24.73M | 22.25M | 19.35M | 8.74M | 8.47M |
| EBITDA | 2.18B | 2.54B | 2.45B | 1.07B | 856.19M | 813.63M | 677.35M | 513.41M | 461.91M | 390.80M | 298.57M | 239.18M | 187.11M | 132.69M | 118.25M |
| EBITDA Ratio | 12.61% | 15.27% | 16.90% | 9.07% | 8.82% | 9.88% | 9.81% | 9.00% | 9.77% | 10.13% | 9.05% | 8.71% | 8.60% | 7.17% | 8.12% |
| Operating Income | 786.44M | 1.66B | 1.07B | 917.93M | 739.22M | 684.33M | 687.38M | 392.58M | 379.01M | 344.43M | 264.34M | 198.89M | 156.33M | 123.95M | 109.78M |
| Operating Income Ratio | 4.55% | 9.53% | 7.32% | 7.25% | 7.05% | 7.46% | 8.87% | 6.28% | 7.12% | 7.78% | 7.45% | 7.00% | 7.05% | 6.70% | 7.54% |
| Total Other Income/Expenses | -83.88M | -7.74M | 28.58M | 38.96M | 9.83M | 7.35M | -140.52M | 18.31M | 11.11M | 916.66K | 5.61M | -11.94M | 1.58M | 1.91M | -5.01M |
| Income Before Tax | 702.56M | 1.23B | 1.10B | 956.89M | 749.05M | 691.68M | 546.86M | 409.38M | 390.13M | 345.34M | 269.95M | 204.82M | 157.90M | 125.86M | 104.77M |
| Income Before Tax Ratio | 4.06% | 7.08% | 7.52% | 7.56% | 7.15% | 7.54% | 7.06% | 6.55% | 7.33% | 7.80% | 7.61% | 7.21% | 7.12% | 6.80% | 7.20% |
| Income Tax Expense | 142.15M | 222.00M | 179.32M | 167.73M | 145.73M | 171.90M | 124.11M | 55.81M | 43.69M | 50.30M | 30.59M | 22.85M | 25.14M | 24.41M | 20.00M |
| Net Income | 549.44M | 1.01B | 921.58M | 789.96M | 603.92M | 521.07M | 422.71M | 353.38M | 346.44M | 297.31M | 240.85M | 182.55M | 134.71M | 102.95M | 84.85M |
| Net Income Ratio | 3.18% | 5.79% | 6.32% | 6.24% | 5.76% | 5.68% | 5.45% | 5.65% | 6.51% | 6.71% | 6.79% | 6.42% | 6.07% | 5.56% | 5.83% |
| EPS | 0.92 | 1.70 | 1.56 | 1.38 | 1.06 | 0.92 | 0.81 | 0.68 | 0.67 | 0.65 | 0.62 | 0.47 | 0.35 | 0.28 | 0.24 |
| EPS Diluted | 0.92 | 1.70 | 1.56 | 1.38 | 1.06 | 0.92 | 0.81 | 0.68 | 0.67 | 0.65 | 0.62 | 0.47 | 0.35 | 0.28 | 0.24 |
| Weighted Avg Shares Out | 596.83M | 593.35M | 590.19M | 572.31M | 567.77M | 567.80M | 520.58M | 520.59M | 520.60M | 455.65M | 390.36M | 390.48M | 390.46M | 370.97M | 351.34M |
| Weighted Avg Shares Out (Dil) | 596.83M | 595.24M | 592.28M | 573.22M | 568.23M | 567.80M | 520.58M | 520.59M | 520.61M | 455.65M | 390.36M | 390.48M | 390.46M | 370.97M | 351.34M |
Source: https://incomestatements.info
Category: Stock Reports